Riskpilot← Back to searchSign inGet full accessCELVIVO ApS
APSActiveCVR 35671099Ørbækvej 264Research and experimental development on natural sciences and engineering · NACE 7210Est. 201421 employees
Revenue 2025
DKK -7,9M
-638% vs 2024
EBITDA margin
259.2%
-99% vs 2024
Equity ratio
-192.7%
Financial strength
Net profit 2025
DKK -45,6M
-118% vs 2024
| Revenue | DKK -7,9M | -638% |
| EBITDA | DKK -20,4M | -99% |
| Net profit | DKK -45,6M | -118% |
| Total assets | DKK 28,2M | -37% |
| Equity | DKK -54,4M | -37% |
| Employees | 21 | — |
Legal name
CELVIVO ApS
CVR number
35671099
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
26. februar 2014
Share capital
DKK 92.840
Employees
21 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens formand i forening med den administrerende direktør eller af to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed med bioteknologi og hermed forbundet virksomhed.
Address
Ørbækvej 264
Phone
+4570228228
Email
mail@celvivo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 82 | 39 | 204 | 202 | 311 | -86 | -2.544 | -1.040 | -2.493 | -1.489 | 1.463 | -7.875 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -733 | -1.945 | -4.278 | -11.279 | -13.308 | -11.700 | -12.540 |
| EBITDA | 7 | 2 | 4 | 14 | 55 | -819 | -4.488 | -5.318 | -13.772 | -14.797 | -10.237 | -20.415 |
| Depreciation & amort. | -1 | -4 | -12 | -77 | -90 | -96 | -90 | -626 | -5.269 | -6.653 | -7.095 | -8.386 |
| EBIT | 6 | -2 | -8 | -63 | -35 | -915 | -4.578 | -5.944 | -19.042 | -21.450 | -17.332 | -28.801 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 5 | -214 | -1.252 | -2.885 | -4.597 | -9.086 | -7.098 |
| Profit before tax | 6 | -2 | -8 | -63 | -35 | -910 | -4.792 | -7.196 | -21.927 | -26.047 | -26.419 | -35.898 |
| Tax | 1 | -0 | -0 | -0 | 1 | -43 | -1.189 | -2.469 | -5.849 | -5.773 | -5.520 | 9.670 |
| Net profit | 5 | -2 | -8 | -63 | -36 | -867 | -3.602 | -4.727 | -16.077 | -20.274 | -20.899 | -45.568 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 80 | 40 | 234 | 203 | 266 | 2.560 | 17.005 | 31.204 | 38.617 | 41.732 | 44.651 | 28.243 |
| Equity | 5 | -2 | 201 | 140 | 231 | 2.470 | -1.133 | -5.475 | -21.543 | -18.863 | -39.712 | -54.426 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 386 | 322 | 1.622 | 1.141 | 706 | 47.029 |
| Short-term debt | 76 | 42 | 33 | 63 | 35 | 91 | 16.498 | 35.044 | 58.538 | 59.454 | 83.657 | 35.640 |
| Total debt | 76 | 42 | 33 | 63 | 35 | 91 | 16.884 | 35.367 | 60.160 | 60.595 | 84.363 | 82.669 |
EBITDA margin
-2041518700.0%
This company
15.8%
Market median
-12921004530% vs market
20142025
Equity ratio
-192.7%
This company
38.2%
Market median
-604% vs market
20142025
Return on equity
-4556808800.0%
This company
18.4%
Market median
-24765265317% vs market
20142025
Net profit margin
-4556808800.0%
This company
8.1%
Market median
-56256898865% vs market
20142025
Asset turnover
-0.28×
This company
1.12×
Market median
-125% vs market
20142025
Debt / equity
1.52×
This company
0.62×
Market median
-145% vs market
20142025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-03-01 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PW Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
SJ Management | Management | 2014 | — | — |
SB Management | Management | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
EnViAc P/S | Company | 33.3% | 33.3% | 2025 |
Danmarks Eksport- og Investeringsfond | Company | 20.0% | 20.0% | 2025 |
T&W HOLDING A/S | Company | 15.0% | 15.0% | 2025 |
FEY HOLDING ApS | Company | 5.0% | 5.0% | 2025 |
KRYSTOF HOLDING ApS | Company | 5.0% | 5.0% | 2025 |
PWA Holding 2019 ApS | Company | 5.0% | 5.0% | 2020 |
Jochumsen Invest ApS | Company | 5.0% | 5.0% | 2023 |
CELVIVO HOLDING IVS | Company | 25.0% | 25.0% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
FEY HOLDING ApS
CELVIVO ApS Board members of CELVIVO ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Willems-Alnøe | Chief Executive Officer | 0 companies |
| Stephen John Fey | Management | 0 companies |
| Søren Baisner Alnøe | Management | 0 companies |
| Tonni Bülow-Nielsen | Board of Directors | 0 companies |
| Lars Nørgaard | Board of Directors | 0 companies |
| Dorthe Mikkelsen | Board of Directors | 0 companies |
| Lene Ploug Bülow | Board of Directors | 0 companies |
| Patrik Olof Dahlén | Chairman | 0 companies |
| Krzysztof Wrzesinski | Board of Directors | 0 companies |